Navigation Links
FDA Director Dr. Wilson Bryan to Address Current Developments in Regenerative Medicine at the 2020 ISPE Biopharmaceutical Manufacturing Conference
Date:3/10/2020

The International Society for Pharmaceutical Engineering (ISPE) announced Wilson Bryan, MD, Director, Office of Tissues and Advanced Therapies, FDA, as a newly confirmed keynote for the 2020 ISPE Biopharmaceutical Manufacturing Conference, taking place 1–3 June 2020 in Boston, Massachusetts.

Wilson Bryan is a neurologist who graduated from the University of Chicago Pritzker School of Medicine. He served on the neurology faculty of the University of Texas Southwestern Medical School for 13 years. He has been an investigator on clinical trials in cerebrovascular disease and neuromuscular disorders, particularly amyotrophic lateral sclerosis. Dr. Bryan joined the United States Food and Drug Administration (FDA) in 2000, and now serves as Director of the Office of Tissues and Advanced Therapies (OTAT) in the FDA’s Center for Biologics Evaluation and Research (CBER).

Dr. Bryan's keynote presentation will provide insights into current developments in regenerative medicine, future trends, and challenges with a special focus on the clinical development of gene therapies for rare diseases and implications for manufacturing.

The 2020 ISPE Biopharmaceutical Manufacturing Conference will focus on innovation in facilities, production methods and technologies that enable a competitive and sustainable biopharmaceutical product supply for the future.? This conference will bring together experts that are developing, implementing, and operating advanced supply chains providing high-quality medicines to global markets.?

Topics that will be addressed at this conference include:

  • Innovations in facility design and operation
  • Cell and gene therapy & biologics GMP
  • Implications of ICH Q12 for biopharma
  • Technology advancements
  • Regulatory updates, insights, and best practices
  • Automation and digitalization
  • Single-use technology
  • Preparing the biopharma workforce of the future

Immediately after the conference, ISPE will provide additional educational opportunities with the 2020 ISPE Continuous Manufacturing Workshop on 3–4 June and in-depth training on 4–5 June.

To explore the agenda and to register 2020 ISPE Biopharmaceutical Manufacturing Conference, please visit ISPE.org/Bio20.

About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 18,500 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland USA, and its operations center in Tampa, Florida USA. Visit http://www.ISPE.org for more information.

For more information, contact:
Amy Henry
Marketing Communications Manager
International Society for Pharmaceutical Engineering (ISPE)
Tel: +1-813-960-2105
Email: ahenry@ispe.org
ISPE.org

Read the full story at https://www.prweb.com/releases/fda_director_dr_wilson_bryan_to_address_current_developments_in_regenerative_medicine_at_the_2020_ispe_biopharmaceutical_manufacturing_conference/prweb16947847.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related medicine technology :

1. FDAnews Announces — Drug Shortages and cGMP/Quality: An Interview with CDER Deputy Director Dr. Douglas C. Throckmorton Webinar, Mar. 18, 2020
2. New Appointments To The Celiac Disease Foundation Board of Directors
3. Election Results for 2020 NCC Board of Directors and Officers
4. The Exceptional Women Awardees Foundation announces that Vanessa Belozeroff, Executive Director, Amgen, joins the EWA January 2020 Cohort of Women Leader Awardees
5. Former Executive Director of Preclinical Safety at Novartis, Klaus Peter Hoffmann, MD, PhD, Joins NDA Partners as Expert
6. AZOVA® and CPESN® USA Announce Directory Services Program and the Launch of CPESN Digital Health Marketplace
7. Former FDA Associate Director for Genomics, Felix Frueh, PhD, Joins NDA Partners as Expert Consultant
8. Coherent Eye Care Announces the Appointment of Justin Manning, OD, MPH as Director of Population Health Strategies and Provider Education
9. Ovation Fertility Announces Addition of New Off-Site Lab Director, Diane Wright, PhD, HCLD/CC
10. Terrence Tormey, CEO of Kibow Biotech, Has Been Elected to the Board of Directors of the American College of Healthcare Trustees
11. Successful Serial Entrepreneur, Hamnett Hill, Joins Breathe Life Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2020)... ... , ... Fifty six percent of older adults think we need to invest ... crisis like COVID-19, according to a new survey by The Senior Citizens League (TSCL). ... voters this year,” says Mary Johnson, a Medicare, and Social Security policy analyst for ...
(Date:8/3/2020)... ... , ... PMI Advisors, a leading management consulting firm, announces ... These plans help ensure that companies actually function and survive should their ... as a result of sickness or injury. , A recent survey of closely-held ...
(Date:7/31/2020)... ... July 31, 2020 , ... As one of the ... been providing residents of Missouri City, TX, with a wide range of professional dental ... is a state-of-the-art dental facility that is not far from the previous clinic location. ...
Breaking Medicine Technology:
(Date:8/5/2020)... ... August 05, 2020 , ... In its often-heroic ongoing ... challenges. Regardless of the obstacle - shortages of tests, ventilators and ICU beds; ... cancellation or postponement of all nonessential services - providers across the country have ...
(Date:8/5/2020)... ... August 05, 2020 , ... The Veterinary Cooperative named ... the largest veterinarian-owned purchasing Cooperative in the United States. , Hamele has spent ... gained extensive knowledge and experience in the animal health industry. In her most ...
(Date:8/5/2020)... Wis. (PRWEB) , ... August 04, 2020 , ... ... the care of children with Autism Spectrum Disorder (ASD) in Wisconsin, is delighted ... Brookfield, Wisconsin . With the opening of their newest center, Total Spectrum now ...
(Date:8/3/2020)... ... 2020 , ... Evolution Labs announced today that St. Lucie ... developed to help students navigate a range of issues related to Mental Health, ... provide their students with preventative lessons after recent studies of social media impact ...
(Date:8/3/2020)... ... August 03, 2020 , ... Actuate Therapeutics, Inc. (Actuate), ... first-line advanced pancreatic cancer in a phase 2 study of 9-ING-41, as a ... 9-ING-41 is Actuate’s proprietary small molecule glycogen synthase kinase-3 beta (GSK-3ß) inhibitor ...
Breaking Medicine News(10 mins):